Noa Wolff

Noa Wolff

Auto-generated profile, based on publicly available information

Noa Wolff

Molecular Diagnostics, AIT Austrian Institute of Technology, Vienna, Austria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2018 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MHMichaela Hendling
Michaela Hendling
SPStephan Pabinger
Stephan Pabinger
KPKonrad Peters
Konrad Peters
NWNoa Wolff
Noa Wolff
RCRick Conzemius
Rick Conzemius
IBIvan Barišić
Ivan Barišić
The success of widely used oligonucleotide-based experiments, ranging from PCR to microarray, strongly depends on an accurate design. The design process involves a number of steps, which use specific parameters to produce high quality oligonucleotides. Oli2go is an efficient, user friendly, fully automated multiplex oligonucleotide design tool, which performs primer and different hybridization probe designs as well as specificity and cross dimer checks in a single run. The main improvement to existing oligonucleotide design web-tools is that oli2go combines multiple steps in an all-in-one solution, where other web applications only accomplish parts of the whole design workflow. Especially, the oli2go specificity check is not only performed against a single species (e.g. mouse), but against bacteria, viruses, fungi, invertebrates, plants, protozoa, archaea and sequences from whole genome shotgun sequence projects and environmental samples, at once. This allows the design of highly specific oligonucleotides in multiplex applications, which is further assured by performing dimer checks not only on the primers themselves, but in an all-against-all fashion. The software is freely accessible to all users at http://oli2go.ait.ac.at/.

16 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NWNoa Wolff
Noa Wolff
MHMichaela Hendling
Michaela Hendling
FSFabian Schroeder
Fabian Schroeder
SSSilvia Schönthaler
Silvia Schönthaler
AGAndreas F. Geiss
Andreas F. Geiss
IBIvan Barišić
Ivan Barišić
Antibiotic resistances progressively cause treatment failures, and their spreading dynamics reached an alarming level. Some strains have already been classified as highly critical, e.g. the ones summarised by the acronym ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.). To restrain this trend and enable effective medication, as much information as possible must be obtained in the least possible time. Here, we present a DNA microarray-based assay that screens for the most important sepsis-relevant 44 pathogenic species, 360 virulence factors (mediate pathogenicity in otherwise non-pathogenic strains), and 409 antibiotic resistance genes in parallel. The assay was evaluated with 14 multidrug resistant strains, including all ESKAPE pathogens, mainly obtained from clinical isolates. We used a cost-efficient ligation-based detection platform designed to emulate the highly specific multiplex detection of padlock probes. Results could be obtained within one day, requiring approximately 4 h for amplification, application to the microarray, and detection.

1 November 2020 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
NWNoa Wolff
Noa Wolff
AGAndreas F. Geiss
Andreas F. Geiss
IBIvan Barišić
Ivan Barišić

1 April 2019 in Sensing and Bio-Sensing Research
Verified
Journal Article
Open access
NWNoa Wolff
Noa Wolff
MHMichaela Hendling
Michaela Hendling
SSSilvia Schönthaler
Silvia Schönthaler
AGAndreas F. Geiss
Andreas F. Geiss
IBIvan Barišić
Ivan Barišić